跳至主要内容
临床试验/NCT06059833
NCT06059833尚未招募不适用

Serum Magnesium Level in Type 2 Diabetes Mellitus

Sohag University1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2023年9月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
120
试验地点
1
主要终点
magnesium perecentage

研究概览

简要总结

Diabetes mellitus (DM) is a chronic metabolic disorder characterized by persistent hyperglycemia. It may be due to impaired insulin secretion, resistance to peripheral actions of insulin, or both . Chronic hyperglycemia in synergy with the other metabolic aberrations in patients with diabetes mellitus can cause damage to various organ systems, leading to the development of disabling and life-threatening health complications, most prominent of which are microvascular (retinopathy, nephropathy, and neuropathy) and macrovascular complications leading to a 2-fold to 4-fold increased risk of cardiovascular diseases Mg2+ deficiency is usually identified by the measurement of serum Mg2+ concentration. Hypomagnesemia is defined by a serum Mg2+ concentration < 0.75 mmol/L, but a deficiency due to low dietary intake in otherwise healthy people is uncommon. Although overt signs of clinical Mg2+ deficiency are not routinely recognized in the healthy population, relatively low Mg2+ intake and/or Mg2+ status have been shown to be associated with chronic diseases, including cardiovascular disease, T2DM, osteoporosis, pulmonary disease, depression, migraine headaches, inflammation, and cancer

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
30 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • • Type 2 Diabetes Mellitus according to WHO criteria.

排除标准

  • • Renal failure patients.
  • Type I DM patients.
  • Acute pancreatitis.
  • Hyperthyroidism.
  • Hyperparathyroidism.
  • Malignancies.
  • Patients on loop/thiazide diuretics.
  • Patients on Mg supplement.
  • Patients on Mg containing antacids.
  • Any other conditions causing low Mg levels were excluded from the study.

结局指标

主要结局

magnesium perecentage

时间窗: 1 year

evaluate serum Mg level in type 2 DM patients.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hasnaa Mohamed Kamel

Resident-clinical pathology department-sohag hospital university

Sohag University

研究点 (1)

Loading locations...

相似试验